CeriBell, Inc. (CBLL) Current Ratio
- Current ratio · latest quarter: Value 9.18×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 9.18× | Current assets / current liabilities. $157.85M ÷ $17.20M ≈ 9.18× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 157.85M USD | Assets, Current |
| Current obligations | 17.20M USD | Liabilities, Current |
| Cash and equivalents | 32.66M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | 96.60M USD | Marketable Securities, Current |
| Customer receivables | 15.99M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 6.74M USD | Inventory, Net |
| Payables | 3.19M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $157.85M | $17.20M | $32.66M | $96.60M | $15.99M | $6.74M | $3.19M | (m) | 9.18× |
| 2026-03-31 | $168.91M | $16.18M | $45.25M | $95.93M | $15.71M | $6.90M | $1.98M | (m) | 10.44× |
| 2025-12-31 | $186.72M | $19.19M | $40.48M | $118.78M | $15.05M | $7.29M | $2.84M | (m) | 9.73× |
| 2025-09-30 | $191.81M | $15.17M | $23.74M | $144.80M | $12.23M | $6.02M | $2.18M | (m) | 12.65× |
| 2025-06-30 | $199.79M | $15.01M | $40.14M | $137.29M | $12.31M | $6.00M | $2.44M | (m) | 13.31× |
| 2025-03-31 | $205.42M | $11.83M | $153.36M | $29.34M | $11.30M | $6.55M | $1.37M | (m) | 17.36× |
| 2024-12-31 | $217.27M | $12.99M | $194.37M | (m) | $10.88M | $6.94M | $1.14M | (m) | 16.73× |
| 2024-09-30 | $34.96M | $13.09M | $14.11M | (m) | $9.97M | $6.91M | $2.78M | (m) | 2.67× |
| 2023-12-31 | $51.96M | $21.60M | $34.49M | (m) | $7.96M | $5.87M | $732.00K | (m) | 2.41× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |